Search for: "Pharmaceutical Staff" Results 201 - 220 of 1,301
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Mar 2021, 7:41 am by Robert Morgus, John Costello
The Cyberspace Solarium Commission, on which we are staff, was asked by Congress in late 2020 to undergo a similar process and propose a strategy and recommendations to secure America’s ICT supply chains. [read post]
18 Mar 2021, 12:49 am by Kluwer Patent Blog
The study, which was carried out by researchers at the Institute for Information Law (IViR) [the authors of this post] and the Joint Institute for Innovation Policy (JIIP), examines the state of the art of copyright and patent protection in Europe for AI-assisted outputs in general and in three priority domains: science (in particular meteorology), media (journalism), and pharmaceutical research. [read post]
18 Mar 2021, 12:47 am by Kluwer Patent blogger
The study, which was carried out by researchers at the Institute for Information Law (IViR) [the authors of this post] and the Joint Institute for Innovation Policy (JIIP), examines the state of the art of copyright and patent protection in Europe for AI-assisted outputs in general and in three priority domains: science (in particular meteorology), media (journalism), and pharmaceutical research. [read post]
12 Mar 2021, 9:57 am by anne
  In so doing, compliance officers and internal audit staff, individuals who are uniquely positioned to detect money laundering violations within their organizations, are invited to step forward and submit a tip to the Treasury Department. [read post]
The post How HR Can Make Staff Redundancies with Tact and Diplomacy appeared first on HR Daily Advisor. [read post]
24 Feb 2021, 6:16 pm by Lebowitz & Mzhen
Finally, there are problems involving drug information, patient information, patient education, and staff education. [read post]
11 Feb 2021, 11:28 am by Dani Selby
Food and Drug Administration) or regulatory work around pharmaceuticals. [read post]
4 Jan 2021, 1:26 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2020 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
28 Dec 2020, 9:03 pm by Series of Essays
The Regulatory Review is pleased to highlight the top essays from 2020 authored by our staff. [read post]
24 Dec 2020, 9:05 pm by Max Masuda-Farkas
In an article for the Yale Journal on Regulation, Charles Silver and David Hyman argue that consumers pay twice for medications—once when taxpayer money funds research, and again when pharmaceutical companies charge monopoly prices on patented drugs. [read post]
20 Dec 2020, 9:06 pm by Mia Cabello
The proposed rule—which would offer no explicit public health benefits—threatens the rescission of thousands of meaningful, science-based regulations, including those concerning food safety and transparency, consumer protections, pharmaceuticals, and health care programs. [read post]
  Additionally, for public school districts, the CDPH had issued guidance specifically for all students, teachers, and staff with the same return to work criteria. [read post]
15 Dec 2020, 6:52 am by Kevin G. Walsh and Marquis A. Whitney
Pharmaceutical innovation has positioned the world to witness the beginning of the largest vaccination effort that humankind has ever seen. [read post]
15 Dec 2020, 6:52 am by Kevin G. Walsh and Marquis A. Whitney
Pharmaceutical innovation has positioned the world to witness the beginning of the largest vaccination effort that humankind has ever seen. [read post]
15 Dec 2020, 6:52 am by Kevin G. Walsh and Marquis A. Whitney
Pharmaceutical innovation has positioned the world to witness the beginning of the largest vaccination effort that humankind has ever seen. [read post]
14 Dec 2020, 8:33 am by Cameron Kerry, John B Morris, Jr.
Roger Wicker’s SAFE DATA Act, and the House Energy and Commerce “bipartisan staff draft” (although the latter does include a bracketed placeholder). [read post]
7 Dec 2020, 9:03 pm by News Desk
Approval could come as early as Friday by the FDA Commissionerc Earlier the CDC advisory committee recommended the top priority for the first 24 million vaccines in the U.S. go to healthcare professionals and elderly residents of long-term care facilities Coming closely behind the Pfizer/BioNTech vaccine are two additional COVID-19 vaccinations, one by the biotech firm Moderna and the other from AstraZeneca, a pharmaceutical company. [read post]
4 Dec 2020, 3:00 am by Christopher Tyner
There have been a number of encouraging recent announcements about coronavirus vaccines, with several pharmaceutical companies saying that they have developed vaccines with a high degree of effectiveness and minor side effects. [read post]
30 Nov 2020, 10:28 am by Bryce Klehm
” These oversight actions include one audit that found “military services did not safeguard pharmaceuticals at facilities supporting OFS” and another that found the State Department “spent $8.4 million for meals neither needed nor provided at U.S. [read post]